Chester County News and Community Website
WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD) has unveiled encouraging results from its ongoing Phase 1 trial of PRT3789, a groundbreaking SMARCA2 degrader, at the 36th Annual EORTC-NCI-AACR Symposium …
Prelude Therapeutics Shares Promising Phase 1 Trial Data for PRT3789 at International Symposium Read More
DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE) recently showcased preliminary safety results for its WEE1 inhibitor, APR-1051, at the EORTC-NCI-AACR Symposium in Barcelona. This data comes from ACESOT-1051, a Phase …
Aprea Therapeutics Presents Promising Safety Data for WEE1 Inhibitor at International Symposium Read More
PHILADELPHIA, PA — Interius BioTherapeutics has taken a significant step forward with the dosing of its first participant in the Phase 1 clinical trial of INT2104, a pioneering gene therapy designed …
Interius BioTherapeutics Launches Innovative Gene Therapy Trial for B-Cell Malignancies Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has announced a significant development in its efforts to treat Stargardt disease, as the Data and Safety Monitoring Board (DSMB) has greenlit the …
Ocugen Advances Stargardt Disease Trial with Promising Gene Therapy Read More
CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has successfully completed enrollment for its MAESTRO-NASH OUTCOMES trial, a critical study evaluating the efficacy of resmetirom in patients with compensated NASH …
Madrigal Pharmaceuticals Advances NASH Treatment with Full Enrollment of MAESTRO-NASH OUTCOMES Trial Read More
RADNOR, PA — Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) showcased new findings from its pivotal Phase 3 RAISE trial at the Neurocritical Care Society Annual Meeting, highlighting the potential of intravenous …
Marinus Pharmaceuticals Unveils Promising Phase 3 Trial Results for IV Ganaxolone in Treating Refractory Status Epilepticus Read More
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) is set to host a conference call on October 31, 2024, at 8:00 a.m. Eastern Time to discuss its third quarter financial results …
Teleflex Announces Third Quarter Financial Call and Highlights Promising Data on Prostate Cancer Treatment Read More
PHILADELPHIA, PA — GSK plc (LSE/NYSE: GSK) has released new data from the AReSVi-006 Phase III trial, demonstrating the efficacy and safety of its RSV vaccine, AREXVY, over three full RSV …
GSK’s AREXVY Vaccine Shows Promising Results Across Three RSV Seasons Read More
WILMINGTON, DE — AstraZeneca has announced promising results from the BATURA Phase IIIb trial, showcasing the effectiveness of AIRSUPRA (albuterol/budesonide) in reducing the risk of severe asthma exacerbations. The trial demonstrated …
AstraZeneca’s AIRSUPRA Proven Effective in Reducing Severe Asthma Attacks Read More
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced the publication of its SEISMiC Phase 2b trial design by the European Society of Cardiology Heart Failure. The trial is exploring …
Windtree Therapeutics Publishes SEISMiC Phase 2b Trial Design for Cardiac Treatment Read More